Studies on the uptake of different arsenic forms and the influence of sample pretreatment on arsenic speciation in White mustard (Sinapis alba)

The concentration and speciation of arsenic incorporated by plants grown in the presence of different arsenic compounds was compared, and the influence of plant sample pretreatment and extraction procedures on the recovery and reliability of speciation analyses was studied. It was concluded that sample pretreatment greatly affected the extraction efficiency, but did not change arsenic speciation. The most suitable extraction procedure involved dried plant material without the use of liquid nitrogen. To assess the ability of White mustard to uptake arsenic in different forms, samples were cultivated in nutrient solutions containing either As(III), As(V), monomethylarsonic acid (MMA) or dimethylarsinic acid (DMA). The translocation factor was the highest (0.70) when DMA was added to the nutrient solution, however the overall As concentration in plant tissues was the lowest in this case. Only inorganic As was found in plant tissues when either As(III) or As(V) was added to the nutrient solution. When organic arsenic was present in the nutrient medium, however, it was partially transformed by the plants into inorganic forms.     

Development and Validation of a UHPLC UV Method for the In-Process Control of Bosentan Monohydrate Synthesis

Bosentan monohydrate (4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl) pyrimidin-4-yl]benzene-1-sulfonamide monohydrate) is a dual endothelin receptor antagonist (ERA) applied in the treatment of pulmonary arterial hypertension. To achieve effective process control of the bosentan monohydrate synthesis, it was necessary to develop a selective and not highly time-consuming method for ultra-high performance liquid chromatography (UHPLC). The method is characterized by adequate sensitivity, reproducibility and selectivity for the determination of bosentan monohydrate and related compounds from all synthetic stages. The UHPLC separation was carried out by reversed phase chromatography on the Acquity BEH C18 column (100 mm × 2.1 mm, 1.7 µm) with a mobile phase composed of solvent A (0.1 %, v/v, acetic acid in water) and solvent B (methanol), in the gradient mode at the flow rate of 0.4 mL min⁻¹. Limits of detection and quantification for the compounds were ≤0.1 µg mL⁻¹ and 0.3 µg mL⁻¹, respectively. The linearity for all related compounds was investigated as in the range for the active pharmaceutical ingredient (API) and as in the range for the in-process control. The developed method was validated according to the current guidelines, proving the suitability of the method for its intended purpose.